Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001185185-24-000674
Filing Date
2024-07-08
Accepted
2024-07-08 16:07:05
Documents
3
Period of Report
2024-08-23

Document Format Files

Seq Description Document Type Size
1 FORM DEF 14A igcpharma20240705_def14a.htm DEF 14A 342468
2 igcpharma_def14aimg001.jpg GRAPHIC 2147
3 igcpharma_def14aimg002.jpg GRAPHIC 1287
  Complete submission text file 0001185185-24-000674.txt   348608
Mailing Address 10224 FALLS ROAD POTOMAC MD 20854
Business Address 10224 FALLS ROAD POTOMAC MD 20854 301-983-0998
IGC Pharma, Inc. (Filer) CIK: 0001326205 (see all company filings)

EIN.: 202760393 | State of Incorp.: MD | Fiscal Year End: 0331
Type: DEF 14A | Act: 34 | File No.: 001-32830 | Film No.: 241104720
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)